Fundamental Valuation Report Rexnord(RXN:NYS) Industrials:Specialty Industrial Machinery This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$30.23 (USD) 09/11/2020 Weighted Valuation$31.70 (USD) Overall RatingFairly valued to slightly Undervalued by 4.8% Valuation Models …
Rexnord (RXN:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Xilinx(XLNX:NAS) Technology:Semiconductors This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$98.65 (USD) 09/11/2020 Weighted Valuation$96.62 (USD) Overall RatingFairly valued to slightly Overvalued by 2.1% Valuation Models Comparables: $107.43 (USD) …
Xilinx (XLNX:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report CarMax(KMX:NYS) Consumer Cyclical:Auto & Truck Dealerships This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$101.63 (USD) 09/11/2020 Weighted Valuation$99.51 (USD) Overall RatingFairly valued to slightly Overvalued by 2.1% …
CarMax (KMX:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report BlackBerry(BB:NYS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.75 (USD) 09/11/2020 Weighted Valuation$4.75 (USD) Overall RatingFairly valued to slightly Overvalued by 0.1% Valuation Models …
BlackBerry (BB:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report BlackBerry(BB:TSE) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.74 (USD) / $6.25 (CAD) 09/11/2020 Weighted Valuation$4.55 (USD) / $5.99 (CAD) Use a …
BlackBerry (BB:TSE) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Uranium Participation(U:TSE) Energy:Uranium This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.30 (CAD) 09/11/2020 Weighted Valuation$4.44 (CAD) Overall RatingFairly valued to slightly Undervalued by 3.1% Valuation Models Comparables: $4.44 …
Uranium Participation (U:TSE) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Abercrombie & Fitch(ANF:NYS) Consumer Cyclical:Apparel Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.26 (USD) 09/11/2020 Weighted Valuation$14.38 (USD) Overall RatingFairly valued to slightly Undervalued by 0.9% …
Abercrombie & Fitch (ANF:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Ross Stores(ROST:NAS) Consumer Cyclical:Apparel Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$90.22 (USD) 09/11/2020 Weighted Valuation$87.50 (USD) Overall RatingFairly valued to slightly Overvalued by 3.0% Valuation …
Ross Stores (ROST:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Shoe Carnival(SCVL:NAS) Consumer Cyclical:Apparel Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$36.39 (USD) 09/11/2020 Weighted Valuation$37.28 (USD) Overall RatingFairly valued to slightly Undervalued by 2.5% Valuation …
Shoe Carnival (SCVL:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report ResMed(RMD:NYS) Healthcare:Medical Instruments & Supplies This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$174.68 (USD) 09/09/2020 Weighted Valuation$171.61 (USD) Overall RatingFairly valued to slightly Overvalued by 1.8% Valuation …
ResMed (RMD:NYS) Fundamental Valuation Report Read more »
Read More